< Back to News & Events

VivaQuant algorithm shows 6-fold reduction in risk classification error relative to FDA published results

This study demonstrates that fully automated continuous beat to beat measurements over 24 hours can be obtained using the Rhythm Express software and used to discriminate multichannel ion block from pure hERG block.

2019-05-22T19:51:43-04:00November 10th, 2018|Company News, Publications|

VivaQuant Technology Shows Promise for Improving Drug Safety Assessment Accuracy

VivaQuant MDSP technology was the subject of a recent manuscript published in The Journal of Pharmacological and Toxicological Methods (JPTM) titled "Comparison of one- and three-lead ECG to measure cardiac intervals and differentiate drug-induced multi-channel block".

2019-05-22T19:53:52-04:00June 11th, 2018|Company News, Publications|

VivaQuant Rhythm Express software demonstrates improved accuracy of cardiac safety assessment markers

Fully automated QT measurements, obtained from VivaQuant Rhythm Express software, with no human review or editing, were shown to improve accuracy of concentration effect models used in drug safety assessment by 22 percent

2019-05-22T19:55:52-04:00November 21st, 2017|Company News, Publications|